# Kyverna Therapeutics, Inc.: Form 8-K, filed Feb 3, 2026

- Company: [Kyverna Therapeutics, Inc.](/companies/kytx.md) (CIK 1994702)
- Form: 8-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 08:00 ET
- Period: 2026-01-29
- Accession: 0001193125-26-034464
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1994702/000119312526034464/kytx-20260129.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1994702/000119312526034464/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1994702/000119312526034464/kytx-20260129.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-034464. Last ingested by Listed: Nov 12, 2026, 18:10 ET. No prices; not investment advice.